Bank of America’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,500
Closed -$86K 8098
2014
Q4
$86K Sell
2,500
-3,700
-60% -$121K ﹤0.01% 5994
2014
Q3
$185K Buy
6,200
+3,500
+130% +$74.2K ﹤0.01% 5454
2014
Q2
$54K Sell
2,700
-1,500
-36% -$34.4K ﹤0.01% 6606
2014
Q1
$114K Buy
4,200
+1,400
+50% +$37.2K ﹤0.01% 5893
2013
Q4
$58K Sell
2,800
-40,900
-94% -$771K ﹤0.01% 6483
2013
Q3
$795K Buy
43,700
+34,900
+397% +$631K ﹤0.01% 4179
2013
Q2
$146K Buy
+8,800
New +$141K ﹤0.01% 5899

Other funds holding AUXL

Bank of America's AUXL Position: Q1 2015 in Review

Bank of America sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 63,716 shares — an estimated $2.19M sold.

Bank of America first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $8.92M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Bank of America reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of America sold 63,716 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $2.19M.
  • Bank of America first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of America's AUXILIUM PHARAMCEUTICALS INC position peaked at $8.92M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.